14天12涨停！603122，明天复牌

Core Viewpoint - The stock of HeFu China (603122) experienced significant volatility, with 12 out of 14 trading days resulting in price limits, leading to a total increase of 256.29% before a temporary suspension for investigation [3][4]. Group 1: Stock Performance and Trading Activity - HeFu China's stock price reached a high of 23.8 yuan per share, with a total market capitalization of 9.474 billion yuan [4]. - The company faced trading suspensions due to abnormal stock price fluctuations, with the stock being suspended on November 17, 2025, and set to resume trading on November 20, 2025 [3][4]. - The stock's trading volume showed significant fluctuations, indicating a "hot potato" effect among investors [4]. Group 2: Financial Performance and Valuation - HeFu China reported a net loss of 5.048 million yuan for Q3 2025, a decline of 225.26% year-on-year, attributed to changes in the macroeconomic environment and price reductions in medical procurement [5]. - The company's static price-to-earnings (P/E) ratio was reported at 343.67, significantly higher than the industry average of 30.94, indicating a potential overvaluation [4]. - Despite implementing cost control measures, the company is facing pressure on its operating performance due to declining sales revenue and profit levels [5].